Post-Treatment Circulating Tumor DNA Clinical Features, Prognosis in HPV-Positive Oropharynx Cancer
Roof, S.A.; Sicard, R.M.; Chennareddy, S.; Ahn, S.; Fu, W.; Gomez, E.; Kraft, D.O.; Cooke, P.; Genden, E.; Teng, M.; et al. Oral Oncol 2026, 178, 108003, http://www.doi.org/10.1016/j.oraloncology.2026.108003
July 2026
Circulating Tumor High Risk HPV DNA as the HPV-Specific Test in Oropharyngeal Squamous Cell Carcinoma Patients
Hidalgo, C.M.; Yin, L.X.; Bogan, A.W.; Lott Limbach, A.; Ma, D.; Van Abel, K.M.; Routman, D.M.; Lewis, J.S. Head Neck Pathol 2026, 20, 51, http://www.doi.org/10.1007/s12105-026-01911-5
May 28, 2026
Risk-Adapted Therapy Guided by Human Papillomavirus (HPV) Circulating Tumor DNA in HPV-Positive Oropharyngeal Cancer (ReACT 1.0): An Exploratory Phase II Trial
Hanna, G.J.; Gupta, T.R.; Trippa, L.; Rettig, E.M.; Margalit, D.N.; Tishler, R.B.; Pashtan, I.; Kim, E.; Droznin, A.; Gunasti, L.; et al. Nat Commun 2026, http://www.doi.org/10.1038/s41467-026-72984-7
May 7, 2026
Minimizing Chemoradiation Using a Surgical Algorithm for HPV‐Associated Cancer of Unknown Primary
Daoud, G.E.; Burnham, A.J.; Vettikattu, N.T.; Schmitt, N.C.; Boyce, B.J.; Gross, J.H.; Baddour, H.M.; El-Deiry, M.W.; Steuer, C.E.; Saba, N.F.; et al. Head & Neck 2026, http://www.doi.org/10.1002/hed.70124
May 2026
Long-Term Results of a Phase II Clinical Trial of Radiation Volume and Dose De-Intensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Lukens, J.N.; Riina, M.D.; Weinstein, G.; MacDuffie, E.; Ramkissoon, A.; Baron, J.; Berger, M.; Messing, I.; Gentile, M.; Maxwell, R.; et al. International Journal of Radiation Oncology*Biology*Physics 2026, http://www.doi.org/10.1016/j.ijrobp.2026.04.015
April 16, 2026
Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer
Birkenbeuel, J.L.; Noel, C.; Baliga, S.; Gogineni, E.; Blakaj, D.M.; Bonomi, M.; Miller, L.E.; Ozer, E.; Agrawal, A.; VanKoevering, K.K.; et al. JAMA Otolaryngol Head Neck Surg 2026, http://www.doi.org/10.1001/jamaoto.2026.0015
April 2, 2026
A Phase II Exploratory Trial Evaluating CT-Based Mid-Treatment Nodal Response to Select for De-Escalated Chemoradiation Therapy in the Definitive Management of P16+ Oropharyngeal Cancer
Kim, J.K.; Tam, M.; Kim, S.G.; Solomon, E.; Hill, C.; Karp, J.M.; Hung, C.; Oh, C.; Concert, C.; Rybstein, M.; et al. International Journal of Radiation Oncology, Biology, Physics 2025, 0, http://www.doi.org/10.1016/j.ijrobp.2025.09.054
March 01, 2026
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)
Chen, L.; Cohen, M.; Hatzglou, V.; Zhang, Z.; Riaz, N.; Shamseddine, A.A.; Morris, L.G.T.; McBride, S.M.; Gelblum, D.Y.; Zakeri, K.; et al. Int J Radiat Oncol Biol Phys 2025, S0360-3016(25)06303-5, http://www.doi.org/10.1016/j.ijrobp.2025.09.044
March 01, 2026
Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA
Kabarriti, R.; Lloyd, S.; Jabalee, J.; Gay, L.M.; Slater, T.; Guzman, K.; Jacobs, C.; Inocencio, S.; Lin, R.; Nguyen, C.; et al. Cancers 2026, 18, 35, http://www.doi.org/10.3390/cancers18010035
December 22, 2025
Diagnostic Accuracy of HPV Circulating Tumor DNA Following Non‐Diagnostic FNA of a Cystic Lateral Neck Mass
Papazian, M.R.; Hicks, M.D.; Mannion, K.; Turner, M.; Topf, M.C. Head & Neck 2025, hed.70060, http://www.doi.org/10.1002/hed.70060
October 7, 2025
Artificial Intelligence Measured Tumor Burden and Pre-Treatment Circulating Tumor DNA in Human Papilloma Virus-Associated Oropharynx Cancer
Bakhtiar, M.; Ye, Z.; Schoenfeld, J.D.; Mohammadi, H.; Guenette, J.P.; Rettig, E.M.; Hanna, G.J.; Kann, B.H. Head & Neck 2025, 47, 2641–2649, http://www.doi.org/10.1002/hed.28180
October 2025
Circulating Tumor Tissue-Modified-Viral HPV DNA and Correlations With Disease Burden in Oropharyngeal Cancer
Lee, J.; McAdoo, A.; Fassler, C.; Sun, T.; Liu, D.; Lockney, N.; Whitaker, R.; Topf, M.C.; Mannion, K. Otolaryngology–Head and Neck Surgery 2025, 173, 911–918, http://www.doi.org/10.1002/ohn.1345
October 2025
Incidence and Outcomes of Radiation-Associated Second Primary Malignancies in HPV-Positive Oropharyngeal Cancer: Long-Term Follow-up of the Quarterback de-Escalation Trials
Lovett, J.T.; Westra, W.H.; Roof, S.; Bakst, R.L.; Sindhu, K.; Genden, E.; Wotman, M.T.; Ivic-Pavlicic, T.; Ahn, S.; Chen, T.; et al. Oral Oncology 2025, 169, 107654, http://www.doi.org/10.1016/j.oraloncology.2025.107654
October 2025
Predictive Value of Circulating Tumor Tissue-Modified HPV DNA Kinetics in Induction Therapy for Oropharyngeal Squamous Cell Carcinoma
Tang, M.; Dougherty, M.; Worona, L.; Ramos, E.; Posner, M.; Roof, S.; Bakst, R.; Sindhu, K.K.; Misiukiewicz, K. Oral Oncology 2025, 169, 107608, http://www.doi.org/10.1016/j.oraloncology.2025.107608
October 2025
Evaluating Clinical Factors Including HPV Clearance on Survival Outcomes in HPV+ Oropharyngeal Carcinoma
Reyes, A.; Maroongroge, S.; Afkhami, M.; Villaflor, V.; Amini, A.; Sampath, S.; Maghami, E.; Gernon, T.; Patel, K.; Li, X.; et al. Cancers 2025, 17, 2802, http://www.doi.org/10.3390/cancers17172802
August 27, 2025
Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Echevarria, M.; Park, R.; Caudell, J.J.; Kim, Y.; Yang, G.Q.; Kirtane, K.; Chaudhary, R.; Kumar, S.; Amelio, A.L.; Giuliano, A.R.; et al. Cancer Res Commun 2025, 5, 1194–1202, http://www.doi.org/10.1158/2767-9764.CRC-25-0180
July 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial
Routman, D.M.; Van Abel, K.M.; Price, K.A.; Moore, E.J.; Patel, S.H.; Hinni, M.L.; Fruth, B.; Foster, N.R.; Yin, L.X.; Neben-Wittich, M.; et al. JAMA Otolaryngol Head Neck Surg 2025, 151, 665–672, http://www.doi.org/10.1001/jamaoto.2025.0903
May 22, 2025
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer
Yin, L.X.; Hidalgo, C.M.; Bogan, A.W.; Hunter, D.E.; Bartemes, K.R.; Tasche, K.K.; Moore, E.J.; Price, D.L.; Ma, D.J.; Neben-Wittich, M.A.; et al. JAMA Otolaryngol Head Neck Surg 2025, 151, http://www.doi.org/10.1001/jamaoto.2025.1606
May 14, 2025
Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue–Modified Viral HPV DNA
Rettig, E.M.; Schoenfeld, J.D.; Miller, J.; Sargent, B.; Carey, E.; Margalit, D.N.; Sehgal, K.; Sethi, R.K.V.; Uppaluri, R.; Tishler, R.B.; et al. Clinical Cancer Research 2025, 31, 1605–1614, http://www.doi.org/10.1158/1078-0432.CCR-24-3053
May 1, 2025
Association Between HPV Circulating Tumor DNA and Prognostic Inflammatory Indices in Oropharyngeal Squamous Cell Carcinoma: A Pilot Study
Ziltzer, R.S.; Jafary, Z.I.; Hunt, C.; Hasan, I.; Turner, M.T. OTO Open 2025, 9, e70116, http://www.doi.org/10.1002/oto2.70116
April-June 2025
Pretreatment Liquid Biopsy and Clinicopathologic Features in HPV−Associated Oropharyngeal Squamous Cell Carcinoma
Cooke, P.V.; Chennareddy, S.; Kraft, D.O.; Kappauf, C.; Lam, A.S.; Chen, S.; Sindhu, K.K.; Berger, M.H.; Ferrandino, R.M.; Kulkarni, R.; et al. JAMA Otolaryngol Head Neck Surg 2025, http://www.doi.org/10.1001/jamaoto.2024.5549
March 13, 2025
Highly-Multiplex Detection of Plasma Cell-Free Human Papillomavirus-16 DNA in Oropharyngeal Carcinoma
Clark, P.; Karasik, N.; Campbell, S.R.; Woody, N.M.; Ku, J.A.; Silver, N.; Bottalico, D.; Prendes, B.L.; Lamarre, E.D.; Scharpf, J.; et al. Journal of Clinical Virology 2025, 176, 105760, http://www.doi.org/10.1016/j.jcv.2025.105760
February 2025
Circulating Tumor DNA Determines Induction Chemotherapy Response in HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Pilot Study
Huttinger, Z.M.; Gogineni, E.; Baliga, S.; Blakaj, D.M.; Bhateja, P.; Bonomi, M.; Kang, S.Y.; Old, M.O.; Seim, N.B.; VanKoevering, K.K.; et al. Oral Oncol 2025, 161, 107179, http://www.doi.org/10.1016/j.oraloncology.2025.107179
February 2025
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence
Kabarriti, R.; Lloyd, S.; Jabalee, J.; Del Vecchio Fitz, C.; Tao, R.; Slater, T.; Jacobs, C.;Inocencio, S.; Rutenberg, M.; Matthiesen, C.; et al. Cancers 2025, 17, 174, http://www.doi.org/10.3390/cancers17020174
January 8, 2025
Impact of Circulating Tumor Human Papillomavirus DNA Kinetics on Disease Outcomes in HPV-Associated Oropharyngeal Cancer
Jhawar, S.R.; Haring, C.; Pan, X.; Ma, J.; Bhateja, P.; Kubi, E.A.; Limbach, A.L.; Gogineni, E.; Mitchell, D.; Konieczkowski, D.; et al. Int J Cancer 2024, http://www.doi.org/10.1002/ijc.35291
December 16, 2024
Follow-up for Human Papillomavirus-Related Oropharynx Cancer Concentrated on Unequal Symptom Change (FOCUS): Prospective Patient-Reported Outcome Collection
Edwards, D.M.; Gharzai, L.A.; Wang, W.; Mayo, C.; Suresh, K.; Schipper, M.; Evans, J.R.; Malloy, K.; Chinn, S.B.; Prince, M.; et al. Head & Neck 2024, 46, 2687–2698, http://www.doi.org/10.1002/hed.27778
November 2024
Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA in Recurrent, Metastatic HPV-Driven Oropharyngeal Cancer
Hanna, G.J.; Jabalee, J.; Lukens, J.N.; Sun, L.; Rettig, E.M.; Ferrandino, R.; Posner, M.R.; Misiukiewicz, K.J.; Routman, D.M.; Van Abel, K.M.; et al. Oral Oncology 2024, 158, 107002, http://www.doi.org/10.1016/j.oraloncology.2024.107002
November 2024
Diagnostic Accuracy of Circulating Tumor HPV DNA Testing in Patients With a Lateral Neck Mass
Ferrandino, R.M.; Barlow, J.; Gold, B.; Kraft, D.; Roof, S.A.; Teng, M.S.; Khan, M.N.; Berger, M.H.; Misiukiewicz, K.J.; Sindhu, K.K.; et al. JAMA Otolaryngol Head Neck Surg 2024, http://www.doi.org/10.1001/jamaoto.2024.2702
September 19, 2024
Patient Perceptions Underlying ctDNA Molecular Surveillance for HPV(+) Oropharyngeal Squamous Cell Carcinoma
Bastien, A.J.; Ng, J.; Cong, I.; Garcia, J.; Walgama, E.S.; Luu, M.; Jang, J.K.; Mita, A.C.; Scher, K.S.; Moyers, J.T.; et al. Oral Oncol 2024, 156, 106894, http://www.doi.org/10.1016/j.oraloncology.2024.106894
September 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
Bauer, A.H.; Alkhateeb, K.J.; Agoston, A.T.; Odze, R.D.; Joshi, M.G.; Huffman, B.M.; Enzinger, P.; Perez, K.; Deshpande, V.; Cleary, J.M.; et al. Am J Surg Pathol 2024, 48, 883–889, http://www.doi.org/10.1097/PAS.0000000000002235
July 2024
Utility of TTMV-HPV DNA in Resolving Indeterminate Findings during Oropharyngeal Cancer Surveillance
Roof, S.A.; Jabalee, J.; Rettig, E.M.; Chennareddy, S.; Ferrandino, R.M.; Chen, S.; Posner, M.R.; Genden, E.M.; Chai, R.L.; Sims, J.; et al. Oral Oncology 2024, 155, 106874, http://www.doi.org/10.1016/j.oraloncology.2024.106874
June 14, 2024
Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease
Lam, D.; Sangal, N.R.; Aggarwal, A.; Rajasekaran, K.; Cannady, S.B.; Basu, D.; Chalian, A.; Weinstein, G.; Brody, R.M. JAMA Otolaryngol Head Neck Surg 2024, 150, 444–450, http://www.doi.org/10.1001/jamaoto.2024.0350
April 4, 2024
Human Papillomavirus Circulating Tumor DNA: A Diagnostic Tool in Squamous Cell Carcinoma of Unknown Primary—a Pilot Study
Kais, A.; Santiago, S.P.; Han, P.C.; Clump, D.A.; Stokes, W.A.; Fancy, T.; Cui, R.; Martin, E.; Turner, M.T. Front. Oncol. 2024, 14, 1376595, http://www.doi.org/10.3389/fonc.2024.1376595
April 1, 2024
Addressing Positive Multi-Cancer Early Detection Tests in Head and Neck Surgery: Experience with Head and Neck Work up for High-Risk Referrals
Fearington, F.W.; Zhao, C.Y.; Romero-Brufau, S.; Moore, E.J.; Price, D.L.; Tasche, K.K.; Yin, L.X.; Kunkel, E.T.; Kisiel, J.B.; Giridhar, K.V.; et al. Oral Oncology 2024, 152, 106809, http://www.doi.org/10.1016/j.oraloncology.2024.106809
May 2024
Preliminary Results from Retrospective Correlation of Circulating Tumor DNA (Ct-DNA) with Imaging for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Agarwal, A.; Bhatt, A.A.; Patel, S.; Bathla, G.; Murray, J.; Rhyner, P. American Journal of Neuroradiology 2024, http://www.doi.org/10.3174/ajnr.A8242
March 12, 2024
Circulating Tumor HPV DNA Assessments after Surgery for Human Papilloma Virus-Associated Oropharynx Carcinoma
Souza, S.S.; Stephens, E.M.; Bourdillon, A.T.; Bhethanabotla, R.; Farzal, Z.; Plonowska-Hirschfeld, K.; Qualliotine, J.R.; Heaton, C.M.; Ha, P.K.; Ryan, W.R. American Journal of Otolaryngology 2024, 45, 104184, http://www.doi.org/10.1016/j.amjoto.2023.104184
March-April 2024
Biomarkers of Pembrolizumab Efficacy in Advanced Anal Squamous Cell Carcinoma: Analysis of a Phase II Clinical Trial and a Cohort of Long-Term Responders
Huffman, B.M.; Singh, H.; Ali, L.R.; Horick, N.; Wang, S.J.; Hoffman, M.T.; Metayer, K.A.; Murray, S.; Bird, A.; Abrams, T.A.; et al. J Immunother Cancer 2024, 12, e008436, http://www.doi.org/10.1136/jitc-2023-008436
January 25, 2024
Circulating Tumor-Tissue Modified HPV DNA Testing in the Clinical Evaluation of Patients at Risk for HPV-Positive Oropharynx Cancer: The IDEA-HPV Study
Batool, S.; Sethi, R.K.V.; Wang, A.; Dabekaussen, K.; Egloff, A.M.; Del Vecchio Fitz, C.; Kuperwasser, C.; Uppaluri, R.; Shin, J.; Rettig, E.M. Oral Oncol. 2023, 147, 106584, http://www.doi.org/10.1016/j.oraloncology.2023.106584
October 12, 2023
Circulating Tumor HPV DNA in Patients with Head and Neck Carcinoma: Correlation with HPV Genotyping
Mijares, K.; Ferrandino, R.; Chai, R.; Roof, S.; Bhardwaj, S.; Posner, M.; Westra, W.H. Am. J. Surg. Pathol. 2023, http://www.doi.org/10.1097/PAS.0000000000002134
September 27, 2023
From Planned Neck Dissection to PET Response to Circulating Tumour DNA: Changes in Post-Treatment Assessment of HPV-Driven Oropharyngeal Cancer
Post, C.M.; Ohaegbulam, K.C.; Mitin, T. J Med Radiat Sci 2024, 71, 21–25, http://www.doi.org/10.1002/jmrs.720
September 15, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-Driven Oropharyngeal Cancer Surveillance
Hanna, G.J.; Roof, S.A.; Jabalee, J.; Rettig, E.M.; Ferrandino, R.; Chen, S.; Posner, M.R.; Misiukiewicz, K.J.; Genden, E.M.; Chai, R.L.; et al. Clin. Cancer Res. 2023, CCR-23-1478, http://www.doi.org/10.1158/1078-0432.CCR-23-1478
August 11, 2023
Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
Ferrandino, R.M.; Chen, S.; Kappauf, C.; Barlow, J.; Gold, B.S.; Berger, M.H.; Westra, W.H.; Teng, M.S.; Khan, M.N.; Posner, M.R.; et al. JAMA Otolaryngology–Head & Neck Surgery 2023, http://www.doi.org/10.1001/jamaoto.2023.1937
July 9, 2023
Relationship of HPV16 E6 Seropositivity with Circulating Tumor Tissue Modified HPV16 DNA before Head and Neck Cancer Diagnosis
Rettig, E.M.; Waterboer, T.; Sim, E.; Faden, D.L.; Butt, J.; Hanna, G.J.; Del Vecchio Fitz, C.; Kuperwasser, C.; Sroussi, H. Oral Oncology 2023, 141, 106417, http://www.doi.org/10.1016/j.oraloncology.2023.106417
May 4, 2023
Novel HPV Associated Oropharyngeal Squamous Cell Carcinoma Surveillance DNA Assay Cost Analysis
Lin, M.G.; Zhu, A.; Read, P.W.; Garneau, J.; McLaughlin, C. Laryngoscope 2023, lary.30701, http://www.doi.org/10.1002/lary.30701
April 18, 2023
Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers
Gunning, A.; Kumar, S.; Williams, C.K.; Berger, B.M.; Naber, S.P.; Gupta, P.B.; Fitz, C.D.V.; Kuperwasser, C. Diagnostics 2023, 13, 15. https://doi.org/10.3390/diagnostics13040725
February 14, 2023
Association of Pretreatment Circulating Tumor Tissue–Modified Viral HPV DNA with Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer
Rettig, E.M.; Wang, A.A.; Tran, N.-A.; Carey, E.; Dey, T.; Schoenfeld, J.D.; Sehgal, K.; Guenette, J.P.; Margalit, D.N.; Sethi, R.; et al. JAMA Otolaryngol Head Neck Surg 2022, http://www.doi.org/10.1001/jamaoto.2022.3282
October 27, 2022
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma
Berger, B.M.; Hanna, G.J.; Posner, M.R.; Genden, E.M.; Lautersztain, J.; Naber, S.P.; Del Vecchio Fitz, C.; Kuperwasser, C. Clin Cancer Res 2022, 28, 4292–4301, http://www.doi.org/10.1158/1078-0432.CCR-22-0562
May 16, 2022
Phase II Multi-Institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Chung, C.H.; Li, J.; Steuer, C.E.; Bhateja, P.; Johnson, M.; Masannat, J.; Poole, M.I.; Song, F.; Hernandez-Prera, J.C.; Molina, H.; et al. Clin. Cancer Res. 2022, 28, 2329–2338, http://www.doi.org/10.1158/1078-0432.CCR-21-3849
March 28, 2022
Detection of Circulating Tumor Human Papillomavirus DNA before Diagnosis of HPV‐positive Head and Neck Cancer
Rettig, E.M.; Faden, D.L.; Sandhu, S.; Wong, K.; Faquin, W.C.; Warinner, C.; Stephens, P.; Kumar, S.; Kuperwasser, C.; Richmon, J.D.; et al. Int. J. Cancer 2022, ijc.33996, http://www.doi.org/10.1002/ijc.33996
March 9, 2022
The Economic Impact of Circulating Tumor-Tissue Modified HPV DNA for the Post-Treatment Surveillance of HPV-Driven Oropharyngeal Cancer: A Simulation
Ward, M.C.; Miller, J.A.; Walker, G.V.; Moeller, B.J.; Koyfman, S.A.; Shah, C. Oral Oncol. 2022, 126, 105721, http://www.doi.org/10.1016/j.oraloncology.2022.105721
March 1, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients with HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Routman, D.M.; Kumar, S.; Chera, B.S.; Jethwa, K.R.; Abel, K.M.V.; Frechette, K.; DeWees, T.; Golafshar, M.; Garcia, J.J.; Price, D.L.; et al. Int. J Radiat. Oncol. Biol. Phys. 2022, 113, 530–538, http://www.doi.org/10.1016/j.ijrobp.2022.02.012
February 11, 2022
Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
Kowalchuk, R.O.; Kamdem Talom, B.C.; Van Abel, K.M.; Ma, D.M.; Waddle, M.R.; Routman, D.M. JAMA Netw. Open 2022, 5, e2144783, http://www.doi.org/10.1001/jamanetworkopen.2021.44783
January 25, 2022
